Johannes Herkel

5.1k total citations
73 papers, 3.5k citations indexed

About

Johannes Herkel is a scholar working on Hepatology, Immunology and Epidemiology. According to data from OpenAlex, Johannes Herkel has authored 73 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 37 papers in Immunology and 31 papers in Epidemiology. Recurrent topics in Johannes Herkel's work include Liver Diseases and Immunity (41 papers), Liver Disease Diagnosis and Treatment (25 papers) and T-cell and B-cell Immunology (23 papers). Johannes Herkel is often cited by papers focused on Liver Diseases and Immunity (41 papers), Liver Disease Diagnosis and Treatment (25 papers) and T-cell and B-cell Immunology (23 papers). Johannes Herkel collaborates with scholars based in Germany, United States and Israel. Johannes Herkel's co-authors include Ansgar W. Lohse, Christoph Schramm, Stephan Kanzler, Antonella Carambia, Peter R. Galle, Dorothee Schwinge, Samuel Huber, Stefan Lüth, Christina Weiler‐Normann and Christian Frenzel and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Johannes Herkel

71 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Herkel Germany 32 1.9k 1.6k 1.2k 566 503 73 3.5k
Ye Htun Oo United Kingdom 37 2.0k 1.1× 1.9k 1.2× 1.7k 1.5× 772 1.4× 436 0.9× 110 4.3k
Weici Zhang United States 33 1.4k 0.7× 1.0k 0.6× 778 0.7× 708 1.3× 526 1.0× 78 2.7k
Hermann E. Wasmuth Germany 38 2.3k 1.2× 2.3k 1.4× 941 0.8× 656 1.2× 701 1.4× 81 4.3k
Hans‐Peter Dienes Germany 31 2.3k 1.3× 2.2k 1.4× 479 0.4× 753 1.3× 795 1.6× 57 4.0k
Michio Imawari Japan 34 1.6k 0.9× 1.4k 0.9× 679 0.6× 544 1.0× 573 1.1× 175 3.7k
Mikio Nishioka Japan 32 1.5k 0.8× 1.3k 0.8× 466 0.4× 454 0.8× 657 1.3× 128 2.8k
Elie‐Serge Zafrani France 26 1.4k 0.8× 1.0k 0.7× 386 0.3× 586 1.0× 342 0.7× 55 2.8k
Giorgio Ballardini Italy 34 2.2k 1.2× 1.6k 1.0× 304 0.3× 760 1.3× 361 0.7× 93 3.3k
Evaggelia Liaskou United Kingdom 21 847 0.5× 781 0.5× 685 0.6× 385 0.7× 349 0.7× 31 1.9k
Robert A. DeAngelis United States 24 1.4k 0.7× 1.1k 0.7× 1.8k 1.5× 857 1.5× 918 1.8× 37 4.2k

Countries citing papers authored by Johannes Herkel

Since Specialization
Citations

This map shows the geographic impact of Johannes Herkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Herkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Herkel more than expected).

Fields of papers citing papers by Johannes Herkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Herkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Herkel. The network helps show where Johannes Herkel may publish in the future.

Co-authorship network of co-authors of Johannes Herkel

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Herkel. A scholar is included among the top collaborators of Johannes Herkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Herkel. Johannes Herkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carambia, Antonella, et al.. (2022). Harnessing the liver to induce antigen-specific immune tolerance. Seminars in Immunopathology. 44(4). 475–484. 12 indexed citations
2.
Casar, Christian, Max Preti, Philip Rosenstiel, et al.. (2022). Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis. Journal of Hepatology. 77(6). 1532–1544. 13 indexed citations
3.
Ghallab, Ahmed, Dorothee Schwinge, Sebastian Zuehlke, et al.. (2020). Aryl Hydrocarbon Receptor Activity in Hepatocytes Sensitizes to Hyperacute Acetaminophen-Induced Hepatotoxicity in Mice. Cellular and Molecular Gastroenterology and Hepatology. 11(2). 371–388. 16 indexed citations
4.
Stein, Stephanie, T Poch, Antonella Carambia, et al.. (2020). IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression. Journal of Hepatology. 74(4). 919–930. 26 indexed citations
5.
Schliffke, Simon, Antonella Carambia, Nuray Akyüz, et al.. (2019). T-cell repertoire profiling by next-generation sequencing reveals tissue migration dynamics of TRBV13-family clonotypes in a common experimental autoimmune encephalomyelitis mouse model. Journal of Neuroimmunology. 332. 49–56. 3 indexed citations
6.
Lohse, Ansgar W., Johannes Herkel, & Christina Weiler‐Normann. (2017). Can Understanding the Pathogenesis of Autoimmune Hepatitis Lead to Rational Therapy?. Digestive Diseases. 35(4). 367–370. 6 indexed citations
7.
Bergmann, Juri, Miryam Müller, Carola Heneweer, et al.. (2016). IL‐6 trans‐signaling is essential for the development of hepatocellular carcinoma in mice. Hepatology. 65(1). 89–103. 119 indexed citations
8.
Schwinge, Dorothee, Antonella Carambia, Alexander Quaas, et al.. (2015). Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis. The Journal of Immunology. 194(6). 2522–2530. 58 indexed citations
9.
Carambia, Antonella, Barbara Freund, Dorothee Schwinge, et al.. (2015). Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice. Journal of Hepatology. 62(6). 1349–1356. 143 indexed citations
10.
Sebode, Marcial, Moritz Peiseler, Dorothee Schwinge, et al.. (2014). Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. Journal of Hepatology. 60(5). 1010–1016. 84 indexed citations
11.
Lüth, Stefan, Jörg Schrader, Antonella Carambia, et al.. (2011). Chronic Inflammatory IFN-γ Signaling Suppresses Hepatocarcinogenesis in Mice by Sensitizing Hepatocytes for Apoptosis. Cancer Research. 71(11). 3763–3771. 25 indexed citations
12.
Huber, Samuel, Felix R. Stahl, Jörg Schrader, et al.. (2009). Activin A Promotes the TGF-β-Induced Conversion of CD4+CD25− T Cells into Foxp3+ Induced Regulatory T Cells. The Journal of Immunology. 182(8). 4633–4640. 98 indexed citations
13.
Carambia, Antonella & Johannes Herkel. (2009). CD4 T cells in hepatic immune tolerance. Journal of Autoimmunity. 34(1). 23–28. 49 indexed citations
14.
Mix, Heiko, Robert Thimme, Golo Ahlenstiel, et al.. (2008). Identification of CD4 T-Cell Epitopes in Soluble Liver Antigen/Liver Pancreas Autoantigen in Autoimmune Hepatitis. Gastroenterology. 135(6). 2107–2118. 33 indexed citations
15.
Lüth, Stefan, Johannes Herkel, Stephan Kanzler, et al.. (2008). Serologic Markers Compared With Liver Biopsy for Monitoring Disease Activity in Autoimmune Hepatitis. Journal of Clinical Gastroenterology. 42(8). 926–930. 97 indexed citations
16.
Herkel, Johannes, Naaman Kam, Neta Erez, et al.. (2004). Monoclonal antibody to a DNA‐binding domain of p53 mimics charge structure of DNA: anti‐idiotypes to the anti‐p53 antibody are anti‐DNA. European Journal of Immunology. 34(12). 3623–3632. 10 indexed citations
17.
Herkel, Johannes, Albert J. Czaja, Stephan Kanzler, et al.. (2002). Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut. 51(2). 259–264. 125 indexed citations
18.
Brunner, Silvia, et al.. (2000). Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. The Lancet. 355(9214). 1510–1515. 222 indexed citations
19.
Herkel, Johannes, Roland Wolkowicz, Pedro Ruiz, et al.. (1998). Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.. PubMed. 58(23). 5447–52. 9 indexed citations
20.
Ruiz, Pedro, Roland Wolkowicz, Ari Waisman, et al.. (1998). Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nature Medicine. 4(6). 710–712. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ye Htun Oo Breakdown of academic impact, for papers by Weici Zhang Breakdown of academic impact, for papers by Hermann E. Wasmuth Breakdown of academic impact, for papers by Hans‐Peter Dienes Breakdown of academic impact, for papers by Michio Imawari Breakdown of academic impact, for papers by Mikio Nishioka Breakdown of academic impact, for papers by Elie‐Serge Zafrani Breakdown of academic impact, for papers by Giorgio Ballardini Breakdown of academic impact, for papers by Evaggelia Liaskou Breakdown of academic impact, for papers by Robert A. DeAngelis
Rankless by CCL
2026